{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:34:33Z","timestamp":1777422873702,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1124\/jpet.115.225516","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T01:40:24Z","timestamp":1439257224000},"page":"117-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Impact of Spironolactone on the Severity of Portal-Systemic Collaterals and Hepatic Encephalopathy in Cirrhotic Rats"],"prefix":"10.1016","volume":"355","author":[{"given":"Shao-Jung","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Sang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teh-Ia","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fa-Yauh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Chun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Chih","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Fang","family":"Hsin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-Ling","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shou-Dong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.115.225516_bib1","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1210\/jc.2001-011799","article-title":"Angiogenesis in human normal and pathologic adrenal cortex","volume":"87","author":"Bernini","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.115.225516_bib2","first-page":"G371","article-title":"Measurement of portal-systemic shunting in the rat by using \u03b3-labeled microspheres","volume":"240","author":"Chojkier","year":"1981","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.115.225516_bib3","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.gastro.2003.12.012","article-title":"Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice","volume":"126","author":"Fernandez","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.115.225516_bib4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2005.02.022","article-title":"Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats","volume":"43","author":"Fernandez","year":"2005","journal-title":"J Hepatol"},{"key":"10.1124\/jpet.115.225516_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.acuro.2013.12.013","article-title":"Angiogenesis inhibition impairs testicular morphology in experimental left varicocele rat model","volume":"38","author":"G\u00f6khan-K\u00f6se","year":"2014","journal-title":"Actas Urol Esp"},{"key":"10.1124\/jpet.115.225516_bib6","first-page":"906","article-title":"Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer","volume":"63","author":"Gupta","year":"2003","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.115.225516_bib7","first-page":"H1150","article-title":"On the validity of blood flow measurement using colored microspheres","volume":"276","author":"Hodeige","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.115.225516_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jcma.2011.10.008","article-title":"Portosystemic collaterals are not prerequisites for the development of hepatic encephalopathy in cirrhotic rats","volume":"75","author":"Hsin","year":"2012","journal-title":"J Chin Med Assoc"},{"key":"10.1124\/jpet.115.225516_bib9","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/eci.12006","article-title":"The influence of sorafenib on hepatic encephalopathy and the mechanistic survey in cirrhotic rats","volume":"42","author":"Hsu","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"10.1124\/jpet.115.225516_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jcma.2012.11.005","article-title":"Management of ascites in patients with liver cirrhosis: recent evidence and controversies","volume":"76","author":"Hsu","year":"2013","journal-title":"J Chin Med Assoc"},{"key":"10.1124\/jpet.115.225516_bib11","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/hep.27679","article-title":"Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats","volume":"61","author":"Hsu","year":"2015","journal-title":"Hepatology"},{"key":"10.1124\/jpet.115.225516_bib12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/hep.25625","article-title":"Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats","volume":"56","author":"Huang","year":"2012","journal-title":"Hepatology"},{"key":"10.1124\/jpet.115.225516_bib13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0022-3565(24)37883-8","article-title":"Aldosterone receptor blockade inhibits increased furosemide-sensitive sodium reabsorption in rats with liver cirrhosis","volume":"287","author":"Jonassen","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.115.225516_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.ki.5000018","article-title":"Biphasic changes of epithelial sodium channel abundance and trafficking in common bile duct ligation-induced liver cirrhosis","volume":"69","author":"Kim","year":"2006","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.115.225516_bib15","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1161\/01.CIR.94.10.2566","article-title":"New activity of spironolactone. Inhibition of angiogenesis in vitro and in vivo","volume":"94","author":"Klauber","year":"1996","journal-title":"Circulation"},{"key":"10.1124\/jpet.115.225516_bib16","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.urology.2012.07.017","article-title":"Effects of angiogenesis inhibition by spironolactone on isolated vas deferens contractility in an experimental varicocele model in rats","volume":"80","author":"K\u00f6se","year":"2012","journal-title":"Urology"},{"key":"10.1124\/jpet.115.225516_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2407-6-9","article-title":"The selective Cox-2 inhibitor celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice","volume":"6","author":"Klenke","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1124\/jpet.115.225516_bib18","first-page":"305","article-title":"Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat","volume":"65","author":"Kountouras","year":"1984","journal-title":"Br J Exp Pathol"},{"key":"10.1124\/jpet.115.225516_bib19","doi-asserted-by":"crossref","first-page":"e34230","DOI":"10.1371\/journal.pone.0034230","article-title":"Spironolactone lowers portal hypertension by inhibiting liver fibrosis, ROCK-2 activity and activating NO\/PKG pathway in the bile-duct-ligated rat","volume":"7","author":"Luo","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/jpet.115.225516_bib20","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.CIR.0000127112.36796.9B","article-title":"Aldosterone enhances ischemia-induced neovascularization through angiotensin II-dependent pathway","volume":"109","author":"Michel","year":"2004","journal-title":"Circulation"},{"key":"10.1124\/jpet.115.225516_bib21","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1097\/01.hjh.0000249698.26983.4e","article-title":"Antiangiogenic effects of spironolactone and other potassium-sparing diuretics in human umbilical vein endothelial cells and in fibrin gel chambers implanted in rats","volume":"24","author":"Miternique-Grosse","year":"2006","journal-title":"J Hypertens"},{"key":"10.1124\/jpet.115.225516_bib22","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0168-8278(97)80473-4","article-title":"Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation","volume":"26","author":"Oberti","year":"1997","journal-title":"J Hepatol"},{"key":"10.1124\/jpet.115.225516_bib23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0008-6363(03)00333-X","article-title":"Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction","volume":"58","author":"Sch\u00e4fer","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.115.225516_bib24","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/hep.510290436","article-title":"Increased angiogenesis in portal hypertensive rats: role of nitric oxide","volume":"29","author":"Sumanovski","year":"1999","journal-title":"Hepatology"},{"key":"10.1124\/jpet.115.225516_bib25","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/0006-291X(92)90483-2","article-title":"Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor","volume":"187","author":"Terman","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.115.225516_bib26","doi-asserted-by":"crossref","first-page":"E1415","DOI":"10.1152\/ajpendo.00419.2013","article-title":"Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet","volume":"305","author":"Wada","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.115.225516_bib27","first-page":"4677","article-title":"Effect of aldosterone and its antagonist on the expression of PAI-1 and TGF-\u03b21 in rat hepatic stellate cells","volume":"7","author":"Wang","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"10.1124\/jpet.115.225516_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/cs0560169","article-title":"Renal sodium retention in cirrhosis: relation to aldosterone and nephron site","volume":"56","author":"Wilkinson","year":"1979","journal-title":"Clin Sci (Lond)"},{"key":"10.1124\/jpet.115.225516_bib29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCRESAHA.108.176008","article-title":"Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology","volume":"104","author":"Wilkinson-Berka","year":"2009","journal-title":"Circ Res"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524191318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524191318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.115.225516","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:36:00Z","timestamp":1739993760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524191318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0022356524191318"],"URL":"https:\/\/doi.org\/10.1124\/jpet.115.225516","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Spironolactone on the Severity of Portal-Systemic Collaterals and Hepatic Encephalopathy in Cirrhotic Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.115.225516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}